DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia

Information source: Hopital Foch
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Anesthesia

Intervention: succinylcholine (Drug); rocuronium (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Hopital Foch

Official(s) and/or principal investigator(s):
Morgan Le Guen, MD, Principal Investigator, Affiliation: Hopital Foch

Overall contact:
Marc Fischler, MD, Phone: 4652442, Ext: 0331, Email: m.fischler@hopital-foch.org

Summary

Myorelaxation is generally used as a part of general anesthesia for interventional rigid bronchoscopy. Succinylcholine is most often used because its short duration of action but rocuronium can be used since sugammadex permits a rapid and complete reversal of the neuromuscular block. The aim of ths study is to compare both agents.

Clinical Details

Official title: Interventional Rigid Bronchoscopy Under General Anesthesia: Influence of the Muscle Relaxant, Succinylcholine or Rocuronium, on the Quality of the Surgical Procedure

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment

Primary outcome: Quality of the surgical procedure

Secondary outcome: Quality of anesthesia

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- patients scheduled for an interventional rigid bronchoscopy under general anesthesia

Exclusion Criteria:

- pregnant woman or woman of childbearing age,

- morbid obesity,

- drug allergy,contra-indication to succinylcholine, rocuronium, sugammadex, propofol,

remifentanil,

- history of central neurological or brain damage,

- psychotropic treatment,

- pacemaker,

- renal failure,

- disease of the neuromuscular junction.

Locations and Contacts

Marc Fischler, MD, Phone: 4652442, Ext: 0331, Email: m.fischler@hopital-foch.org

Hopital Foch, Suresnes, Ile de France 92151, France; Recruiting
Morgan Le Guen, MD, Phone: 46252442, Ext: 00331, Email: m.leguen@hopital-foch.org
Additional Information

Starting date: January 2012
Last updated: April 17, 2012

Page last updated: February 07, 2013

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014